Determination of presence of resistance to erythromycin and tetracycline antibiotics in isolated streptococcus species from group C and group G

Acta Veterinaria

Volumn 60, Issue 5-6, 2010, Pages 487-495

  Ljiljana, Pavlović ^c   Edita, Grego ^c   Sandra, Šipetić Grujičić ^a   Jadranka, Žutić ^b   Jelena, Ašanin ^b   Pavlovic N ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Scientific Veterinary Institute of Serbia   (Serbia)

^c Public Health Institute of Belgrade   (Serbia)

Author keywords

Groups C and G; Macrolide resistance; Streptococcus; Tetracycline resistance

Indexed keywords

STREPTOCOCCUS;

EID: 78651277570     PISSN: 05678315     EISSN: None     Source Type: Journal    
DOI: 10.2298/AVB1006487P     Document Type: Article

References (34)

1. Ashley Robinson D, Sutcliffe JA, Tewodros W, Manoharan A, Bessen DE, 2006, Evolution and global dissemination of macrolide-resistant group A streptococci, Antimicrob Agents Chemother, 50, 2903-11. (Pubitemid 44396391)
2. Ayer V, Tewodros W, Manoharan A, Skariah S, Luo F, Bessen DE, 2007, Tetracycline resistance in group A streptococci: emergence on a global scale and influence on multiple-drug resistance, Antimicrob Agents Chemother, 51, 1865-8. (Pubitemid 46744176)
3. Barquero N, Chanter N, Laxton R, Wood JLN, Newton JR, 2009, Molecular epidemiology of Streptococcus zooepidemicus isolated from the respiratory tracts of Thoroughbred racehorses in training, Vet J, article in press.
4. Chalker VJ, Brooks HW, Brownlie J, 2003, The association of Streptococcus equi subsp. zooepidemicus with canine infectious respiratory disease, Vet Microb, 95, 149-56. (Pubitemid 36829326)
5. Chopra J, Roberts M, 2001, Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance, Microbiol Rev, 65, 232-60. (Pubitemid 32538179)
6. Clinical and Laboratory Standards Institute, 2008, Performance standards for antimicrobial susceptibility testing, Document M100-S18.
7. Ergin A, Ercis S, Hascelik G, 2003, In vitro susceptibility, tolerance and MLS resistance phenotypes of group C and group G streptococci isolated in Turkey between 1995 and 2002, Int J Antimicrob Agents, 22, 160-3. (Pubitemid 36970176)
8. Gattringer R, Sauermann R, Lagler H, Stich K, Buxbaum A, Graninger W et al., 2004, Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes colleceted in Austria and Hungary, Int J Antimicrob Agents, 24, 92-5.
9. Giovanetti E, Brenciani A, Lupidi R, Roberts MC, Varaldo PE, 2003, Presence of the tet(O) gene in erythromycin-and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene, Antimicrobial Agents Chemother, 47, 2844-9. (Pubitemid 37040257)
10. Grivea I N, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR, 2006, Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis, Antimicrob Agents Chemother, 50, 256-61. (Pubitemid 43042930)
11. Harrington DJ, Sutcliffe I, Chanter N, 2002, The molecular basis of Streptococcus equi infection and disease, Microb Infect, 4, 501-10. (Pubitemid 34270687)
12. Hung SW, Wang SL, Tu CY, Tsai YC, Chuang ST, Shieh MT et al., 2008, Antibiotic susceptibility and prevalence of erythromycin ribosomal methylase gene, erm(B) in Streptococcus spp., Vet J, 176, 197-204.
13. Ioannidou S, Papaparaskevas J, Tassios PT, Foustoukou M, Legakis NJ, Vatopoulos AC, 2003, Prevalence and characterization of the mechanizms of macrolide, lincosamide and streptogramin resistance in viridans group streptococci, Int J Antimicrob Agents, 22, 626-9. (Pubitemid 37495001)
14. Kim HN, Park JP, Jeon SH, Lee YJ, Choi HJ, Jeong KM et al., 2002, Purulent pericarditis caused by group G Streptococcus as an initial presentation of colon cancer, J Korean Med Sci, 17, 571-3.
15. Kim MK, Jee H, Shin SW, Lee BC, Pakhrin B, Yoo HS et al., 2007, Outbreak and control of haemorrhagic pneumonia due to Streptococcus equi subspecies zooepidemicus in dogs, Vet Rec, 161, 528-30.
16. Krnjaić D, Mišić D, Ašanin R, 2005, Investigation of sensitivity and resistance to antibiotics and chemiotherapeutics in E. coll strains isolated from animals bred in intensive farming conditions, Acta Vet, 55, 501-9.
17. Littauer P, Caugant DA, Sangvik M, Hoiby EA, Sunds fjord A, Simonsen GS, 2006, Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants, Antimicrob Agents Chemother, 50, 1896-9.
18. Luthje R Schwarz S, 2006, Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet, lnt J Antimicrob Agents, 29, 528-35.
19. Luyx C, Vanpee D, Glupczynski Y, Swine C, Gillet JB, 2001, Delayed diagnosis of meningitis caused by β-haemolytic group G Streptococcus in an older woman, J Emerg Med, 21, 393-6. (Pubitemid 33122103)
20. Malhotra-Kumar S, Lammens C, Martel, Mallentjer C, Chapelle S, Verhoeven J et al., 2004, Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium, J Antimicrob Chemother, 53, 271-6.
21. Malini A, Mohiyuddin SMA, Brahmadathan KN, Prasad SR, 2004, Extensive deep neck space abscess due to β-haemolytic group G streptococci-a case report, Ind J Med Microb, 22, 263-5.
22. Martel A, Devriese LA, Decostere A, Haesebrouck F, 2003, Presence of macrolide resistance genes in streptococci and enterococci isolated from pigs and pork carcasses, Int J Food Microb, 84, 27-32.
23. Martinez S, Amoroso AM, Famiglietti A, de Mier C, Vay C, Gitkind GO, 2004, Genetic and phenotypic characterization of resistance to macrolides in Streptococus pyogenes from Argentina, Int J Antimicrob Agents, 23, 95-8.
24. Newton JR, Laxton R, Wood JLN, Chanter N, 2008, Molecular epidemiology of Streptococcus zooepidemicus infection in naturally occuring equine respiratory disease, Vet J, 175, 338-45.
25. Nielsen HU, Hammerum K, Ekelund K, Bang D, Pallesen LV, Frimodt-Moller N, 2004, Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes?, Microb Drug Resist, 10, 231-8.
26. Perez-Trallero E, Montes M, Orden B, Tamayo E, Garcia-Arenzana JM, Marimon JM, 2007, Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005, Antimicrob Agents Chemother, 51, 1228-33.
27. Pesavento PA, Hurley KF, Bannasch MJ, Artiushin S, Timoney JF, 2008, A clonal outbreak of acute fatal haemorrhagic pneumonia in intensively housed dogs caused by Streptococcus equi subsp. zooepidemicus. Vet Path, 45, 51-3.
28. Rodriguez-Avial I, Rodriguez-Avial C, Culebras E, Picazo JJ, 2003, Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes, lnt J Antimicrob Agents, 21, 536-41.
29. Sangvik M, Littauer P, Simonsen GS, Sundsfjord A, Dahl KH, 2005, mef(A), mef(E), and a new met allele in macrolide-resistant Streptococcus spp. isolates from Norway, J Antimicrob Chemother, 56, 841-6. (Pubitemid 41631906)
30. Seppala H, Nissinen A, Yu Q, Houvinen P, 1993, Three different phenotypes of erythromycinresistant Streptococcus pyogenes in Finland, J Antimicrob Chemother, 32, 885-91. (Pubitemid 24026589)
31. Taylor SD, Wilson WD, 2006, Streptococcus equi subsp. equi (Strangles) infection, Clin Tech Equine Pract, 5, 211-7.
32. Tong SHY, tang WM, Wong JWK, 2003, Group G Streptococcus-a rare cause of osteomyelitis simulating bone tumor: A case report, J Orthop Surg, 11, 221-3.
33. Uh Y, Hwang GY, Jang IH, Cho HM, Noh SM, Kim HY et al., 2007, Macrolide resistance trends in β-haemolytic streptococci in a tertiary Korean hospital, Yonsei Med J, 48, 773-8. (Pubitemid 350130466)
34. Zaoutis T, Attia M, Gross R, Klein J, 2004, The role of group C and group G streptococci in acute pharyngitis in children, Clin Microbiol Infect, 10, 37-40. (Pubitemid 38128590)